Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 13
2022 8
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
MicroRNAs regulating SOX2 in cancer progression and therapy response.
Mirzaei S, Saebfar H, Gholami MH, Hashemi F, Zarrabi A, Zabolian A, Entezari M, Hushmandi K, Samarghandian S, Aref AR, Ashrafizadeh M, Khan H. Mirzaei S, et al. Among authors: gholami mh. Expert Rev Mol Med. 2021 Sep 29;23:e13. doi: 10.1017/erm.2021.15. Expert Rev Mol Med. 2021. PMID: 34583803 Review.
The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. Mirzaei S, et al. Among authors: gholami mh. J Hematol Oncol. 2022 Mar 2;15(1):18. doi: 10.1186/s13045-022-01235-1. J Hematol Oncol. 2022. PMID: 35236381 Free PMC article. Review.
Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy.
Mirzaei S, Gholami MH, Zabolian A, Saleki H, Bagherian M, Torabi SM, Sharifzadeh SO, Hushmandi K, Fives KR, Khan H, Ashrafizadeh M, Zarrabi A, Bishayee A. Mirzaei S, et al. Among authors: gholami mh. Curr Mol Pharmacol. 2023 Feb 23;16(3):280-306. doi: 10.2174/1874467215666220415131344. Curr Mol Pharmacol. 2023. PMID: 35430977 Review.
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.
Paskeh MDA, Mehrabi A, Gholami MH, Zabolian A, Ranjbar E, Saleki H, Ranjbar A, Hashemi M, Ertas YN, Hushmandi K, Mirzaei S, Ashrafizadeh M, Zarrabi A, Samarghandian S. Paskeh MDA, et al. Among authors: gholami mh. Biomed Pharmacother. 2022 Feb;146:112532. doi: 10.1016/j.biopha.2021.112532. Epub 2021 Dec 11. Biomed Pharmacother. 2022. PMID: 34906772 Free article. Review.
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression.
Ashrafizadeh M, Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Raei M, Hushmandi K, Zarrabi A, Voelcker NH, Aref AR, Hamblin MR, Varma RS, Samarghandian S, Arostegi IJ, Alzola M, Kumar AP, Thakur VK, Nabavi N, Makvandi P, Tay FR, Orive G. Ashrafizadeh M, et al. Among authors: gholami mh. Carbohydr Polym. 2021 Nov 15;272:118491. doi: 10.1016/j.carbpol.2021.118491. Epub 2021 Jul 27. Carbohydr Polym. 2021. PMID: 34420747 Free article. Review.
23 results